Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 10,114,026 | 10/30/2018 | 2015-070 |
Glycosylation is a heterogeneous and substoichiometric post-translational modification (PTM) on proteins. Glycan heterogeneity directly translates to difficulties in the detection and identification of glycopeptides in glycoproteomics.
Researchers at the University of California, Berkeley have recently developed a targeted, mass independent chemical glycoproteomics platform for characterization of intact, metabolically labeled glycopeptides. This novel technology utilizes the multifunctional cleavable probe for enrichment of labeled glycoproteins, and imparts an isotopically recoded mass envelope to the released glycopeptides. The recoded mass envelope is used as a selection factor for targeted glycoproteomics, and isotopically recoded glycopeptides are selected for tandem MS analysis at a four-fold higher rate. We identified over 550 glycopeptide isoforms from 240 proteins across Jurkat, PC-3, and MCF-7 cancer cell lines. Targeted analysis of tagged species facilitated the high confidence assignment of intact glycopeptides that were not present in the predicted protein database.